Welcome to the ESC Action Center, where you’ll find breaking news and insights from the 2024 European Society of Cardiology (ESC) Congress. Explore pivotal presentations, innovative research findings, and emerging treatments to stay at the forefront of the latest advancements in cardiology.
Economic burden of CVD in 50 ESC member countries
Economic burden of CVD in 50 ESC member countries
Main messages of the 2024 ESC hypertension guidelines
Main messages of the 2024 ESC hypertension guidelines
Optimizing GDMT in HF with digital consults
Optimizing GDMT in HF with digital consults
Continuation or interruption of OAC during TAVI?
Continuation or interruption of OAC during TAVI?
Effects of empagliflozin on cardiac remodeling post-MI
Effects of empagliflozin on cardiac remodeling post-MI
Beneficial effects of MRAs in HF across the LVEF spectrum
Beneficial effects of MRAs in HF across the LVEF spectrum
Effects of empaglifozin on kidney outcomes after acute MI
Effects of empaglifozin on kidney outcomes after acute MI
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
Intensive and early lowering of atherogenic lipids after MI
Intensive and early lowering of atherogenic lipids after MI
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
